Clinical TrialID 6919
Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT01742637
Acne Vulgaris
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6919
- Evidence Id
- 6919
- Core Evidence Id
- 6919
- Source Clinical Trial Id
- 6911
- Herb2 Clinical Trial Id
- HBCT006911
- Nct Id
- NCT01742637
- Title
- Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Acne Vulgaris
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|DRUG: Epiduo® Gel|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 2008
- Outcome Measure
- Inflammatory and non-inflammatory lesion counts, Percent change from baseline to week 12 in the inflammatory (papules and pustules) and non-inflammatory (open and closed comedones) lesion counts., Week 12
- Sponsor Collaborator
- Taro Pharmaceuticals USA
- Funded By
- INDUSTRY
- Location
- Other Id
- ADBG-1206, 1302
- Start Date
- 2012-10
- Primary Completion Date
- 2014-02
- Completion Date
- 2014-03
- First Posted
- 2012-12-05
- Results First Posted
- Last Update Posted
- 2017-05-04
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01742637
- Title Cn
- Title En
- Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
- Bilingual Status
- semi_complete